{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:55:35Z","timestamp":1760266535018},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2000,3,1]],"date-time":"2000-03-01T00:00:00Z","timestamp":951868800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1007\/s10434-000-0155-1","type":"journal-article","created":{"date-parts":[[2005,2,26]],"date-time":"2005-02-26T01:56:04Z","timestamp":1109382964000},"page":"155-159","source":"Crossref","is-referenced-by-count":21,"title":["Hyperthermic Isolated Limb Perfusion With Tumor Necrosis Factor-? and Melphalan in Advanced Soft-Tissue Sarcomas: Histopathological Considerations"],"prefix":"10.1007","volume":"7","author":[{"given":"Josephine","family":"Issakov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Merimsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mordechai","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yehuda","family":"Kollender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dina","family":"Lev-Chelouche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soubhi","family":"Abu-Abid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Lifschitz-Mercer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moshe","family":"Inbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Klausner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac","family":"Meller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"963","DOI":"10.4049\/jimmunol.138.3.963","volume":"138","author":"AL Asher","year":"1987","unstructured":"Asher AL, Mule JY, Reichert CM, Shiloni E, Rosenberg SA. Studies of the antitumor efficacy of systematically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 1987;138:963?974.","journal-title":"J Immunol"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1129::AID-CNCR11>3.0.CO;2-1","volume":"79","author":"M Gutman","year":"1997","unstructured":"Gutman M, Inbar M, Lev-Shlush D, et al. High dose tumor necrosis factor-a and melphalan administered via isolated limb perfusion for advanced limb soft tissue sarcoma results .90% response rate and limb preservation. Cancer 1997;79:1129?1137.","journal-title":"Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/jnci\/80.13.1039","volume":"80","author":"DR Spriggs","year":"1988","unstructured":"Spriggs DR, Sherman ML, Michie H, et al. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion: a phase I and pharmacologic study. J Natl Cancer Inst 1988;80:1039?1044.","journal-title":"J Natl Cancer Inst"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1084\/jem.163.3.740","volume":"163","author":"PP Nawroth","year":"1986","unstructured":"Nawroth PP, Stern DM. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med 1986;163:740?755.","journal-title":"J Exp Med"},{"key":"CR5","first-page":"2179","volume":"49","author":"N Watanabe","year":"1988","unstructured":"Watanabe N, Niitsu Y, Umeno H, et al. Toxic effect of TNF on tumor vasculature in mice. Cancer Res 1988;49:2179?2183.","journal-title":"Cancer Res"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/ijc.2910530521","volume":"53","author":"S Folli","year":"1993","unstructured":"Folli S, Pelegrin A, Chalandon Y, et al. Tumor necrosis factor can enhance radio-antibody uptake in human colon carcinoma xenografts by increasing vascular permeability. Int J Cancer 1993;53:829?835.","journal-title":"Int J Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1200\/JCO.1987.5.12.1942","volume":"5","author":"PB Chapman","year":"1987","unstructured":"Chapman PB, Lester TJ, Casper ES, et al. Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancer. J Clin Oncol 1987;5:1942?1951.","journal-title":"J Clin Oncol"},{"key":"CR8","first-page":"1436","volume-title":"Cancer Principles and Practice of Oncology","author":"SA Rosenberg","year":"1993","unstructured":"Rosenberg SA, Suit HD, Barker LH. Sarcomas of soft tissue. In: Devita VT., Hellman S, Rosenberg SA, eds. Cancer Principles and Practice of Oncology. Philadelphia: JB Lippincott, 1993:1436?1488."},{"key":"CR9","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1126\/science.3764421","volume":"234","author":"KJ Tracey","year":"1986","unstructured":"Tracey KJ, Beutler B, Lowry SF, et al. Shock and tissue injury induced by recombinant human cachectin. Science 1986;234:470?473.","journal-title":"Science"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1200\/JCO.1992.10.1.52","volume":"10","author":"D Lienard","year":"1992","unstructured":"Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52?60.","journal-title":"J Clin Oncol"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1200\/JCO.1996.14.10.2653","volume":"14","author":"AMM Eggermont","year":"1996","unstructured":"Eggermont AMM, Schraffordt Koops H, et al. Isolated limb perfusion with high-dose tumor necrosis factor ain combination with interferon-g and melphalan for nonresectable extremity soft tissue sarcomas: a multicentric trial. J Clin Oncol 1996;14:2653?2657.","journal-title":"J Clin Oncol"},{"key":"CR12","volume-title":"Bone Tumors: Diagnosis, Treatment and Prognosis","author":"A Huvos","year":"1991","unstructured":"Huvos A. Bone Tumors: Diagnosis, Treatment and Prognosis. Philadelphia: WB Saunders, 1991."},{"key":"CR13","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/1097-0142(19940315)73:6<1644::AID-CNCR2820730616>3.0.CO;2-V","volume":"73","author":"ES Carper","year":"1994","unstructured":"Carper ES, Gaynor JJ, Harrison LB, et al. Preoperative and postoperative adjuvant chemotherapy for adults with high grade soft tissue sarcoma. Cancer 1994;73:1644?1648.","journal-title":"Cancer"},{"key":"CR14","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/00000658-199004000-00015","volume":"211","author":"GM Pezzi","year":"1990","unstructured":"Pezzi GM, Pollock RE, Evans HL, et al. Preoperative chemotherapy for soft tissue sarcoma of the extremities. Ann Surg 1990;211:476?481.","journal-title":"Ann Surg"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-510X(98)00098-7","volume":"158","author":"VE Drory","year":"1998","unstructured":"Drory VE, Lev D, Groozman GB, Gutman M, Klausner JM. Neurotoxicity of isolated limb perfusion with tumor necrosis factor. J Neurol Sci 1998;158:1?4.","journal-title":"J Neurol Sci"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/1097-0142(19871015)60:8<1703::AID-CNCR2820600802>3.0.CO;2-J","volume":"60","author":"HJ Hoekstra","year":"1987","unstructured":"Hoekstra HJ, Schraffordt Koops H, Molenaar WM, Oldhoff J. Results of isolated regional perfusion in the treatment of malignant soft tissue tumors of the extremities. Cancer 1987;60:1703?1707.","journal-title":"Cancer"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/brain\/118.4.869","volume":"118","author":"EJ Redford","year":"1995","unstructured":"Redford EJ, Hall SM, Smith KJ. Vascular changes and demyelination induced by the intraneural injection of tumor necrosis factor. Brain 1995;118:869?878.","journal-title":"Brain"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1002\/1097-0142(19940115)73:2<483::AID-CNCR2820730238>3.0.CO;2-S","volume":"73","author":"M Vaglini","year":"1994","unstructured":"Vaglini M, Belli F, Ammatuna M, et al. Treatment of primary or relapsing limb Cancer by isolation perfusion with high dose alpha tumor necrosis factor, gamma interferon, and melphalan. Cancer 1994;73:483?492.","journal-title":"Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-000-0155-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10434-000-0155-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10434-000-0155-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T11:58:31Z","timestamp":1683028711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10434-000-0155-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,3]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1007\/s10434-000-0155-1","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}